SCHEMBL14256554

SCHEMBL14256554

c1ccc(Oc2ccccc2Nc2nc(NC3CCCC3)c3ccccc3n2)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MERTK Q12866 7/20 0.61
▸ NPY5R Q15761 1/20 0.54
▸ TLR7 Q9NYK1 3/20 0.52
▸ PDE5A O76074 2/20 0.51
▸ ACP1 P24666 2/20 0.51
▸ OGG1 O15527 1/20 0.50
▸ MEN1 O00255 2/20 0.47
▸ HSP90AA1 P07900 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ GBA1 P04062 1/20 0.47
▸ CCR4 P51679 1/20 0.46
▸ USP2 O75604 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ CLK4 Q9HAZ1 1/20 0.46
▸ PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14256556 0.84 MERTK (0.81) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL14256561 0.83 MERTK (0.67) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL14256632 0.81 MERTK (0.70) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL14266691 0.79 MERTK (0.50) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL14256538 0.79 MERTK (0.50) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL27224044 0.78 MERTK (0.81) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL24649614 0.77 NPY5R (0.79) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL14256774 0.77 APP (0.60) MERTKNPY5RPDE5AACP1OGG1
SCHEMBL14256549 0.77 MERTK (0.58) MERTKNPY5RTLR7PDE5AACP1
SCHEMBL14256531 0.76 MERTK (0.65) MERTKNPY5RACP1MEN1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2008-03-06 — — US disclosed
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2008-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity HGF, MET, HDGF MERTK 58/4885NPY5R 3095/4885TLR7 2612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback